Prospective Analysis of the Feasibility of the PASCAL Spacer Technology for Transcatheter Mitral Valve Repair in an All-comers Cohort

NCT04473092 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-11-03

No results posted yet for this study

Summary

To identify changes on mitral valve morphology and functionality by the application of the PascalTM in MR.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

TMVR

Patients who undergo TMVR for MR at the PI´s site

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Principal Investigators

  • Peter Lüdike, MD · University Hospital Essen, Westgerman Heart- and Vascular Center, Department of Cardiology and Vascular Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-09-20
Completion
2022-09-30
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473092 on ClinicalTrials.gov